Very small activity doses for COPD symptoms
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests whether “micro-doses” of physical activity (short, small amounts) can help people with COPD. It aims to see if these small activity bursts are safe and beneficial for people who have stable COPD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD and you do not currently smoke (or quit more than 6 months ago).
- Your COPD is considered moderate to severe and has been stable (no flare-ups for over 6 weeks).
- You are not doing structured exercise training or pulmonary rehabilitation right now.
- You do not have certain blood-clot or heart/brain circulation problems (like a history of deep vein thrombosis, stroke, heart attack, or significant heart failure).
- You are not taking blood thinners (anticoagulant medicines).
- You have no physical limitations that prevent you from being active, and they can get the needed blood-vessel ultrasound measurements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
This Phase 2 trial tests whether sildenafil tablets can improve exercise ability, shortness of breath, and heart-lung function in people with COPD. It also compares against people without COPD to better understand how sildenafil affects breathing tests.
This study looks at how COPD affects your breathing and heart health. It is for people who are newly diagnosed with COPD and have a history of smoking.
This trial studies a detailed, whole-body program to improve outcomes in people with COPD or heart failure, especially those who also have several other chronic conditions. It may help by improving activity and monitoring health markers over about 24 weeks.
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
This early study measures how well your blood vessels work using tests that may include MRI. It compares healthy people with people who have conditions like COPD, pulmonary arterial hypertension, heart failure, or high blood pressure, to better understand “vascular function” in health and disease.
Hear when a new Endothelial Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.